Influence of Diagnostic Method on Outcomes in Phase 3 Clinical Trials of Bezlotoxumab for the Prevention of Recurrent Clostridioides difficile Infection: A Post Hoc Analysis of MODIFY I/II

BACKGROUND: The optimum diagnostic test method for Clostridioides difficile infection (CDI) remains controversial due to variation in accuracy in identifying true CDI. This post hoc analysis examined the impact of CDI diagnostic testing methodology on efficacy outcomes in phase 3 MODIFY I/II trials....

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Open Forum Infect Dis
Autori principali: Wilcox, Mark H, Rahav, Galia, Dubberke, Erik R, Gabryelski, Lori, Davies, Kerrie, Berry, Claire, Eves, Karen, Ellison, Misoo C, Guris, Dalya, Dorr, Mary Beth
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2019
Soggetti:
Major Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6677672/
https://ncbi.nlm.nih.gov/pubmed/31375837
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofz293
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi